Vice President of Translation; Director, Cardiovascular Research
Robert A. Kloner MD, PhD, is Director of the HMRI Cardiovascular Research Institute and Vice President of Translation at the Huntington Medical Research Institutes in Pasadena, CA. (starting 2015) and Professor of Medicine (Clinical Scholar) at the Keck School of Medicine at University of Southern California in Los Angeles (2016). From 1988 until 2014 he was Professor of Medicine, in the Cardiovascular Division, Keck School of Medicine, at the University of Southern California, in Los Angeles; in 2015 he was Professor of Clinical Medicine at the Keck School of Medicine at the University of Southern California. He also was Director of Research of the Heart Institute of Good Samaritan Hospital in Los Angeles (1987-2014). He is an attending cardiologist at Los Angeles County/University of Southern California Medical Center.
Dr. Kloner received his MD in the Honors Program in Medical Education and PhD (Experimental Pathology) degrees from Northwestern University Medical School in Chicago where he trained in the laboratory of Dr. Robert Jennings. Dr. Kloner is a member of Alpha Omega Alpha honor society. He completed internship and residency in internal medicine at Peter Bent Brigham Hospital in Boston, Massachusetts. Additional training included clinical and research fellowships in medicine and cardiology (with Drs. Eugene Braunwald and Peter Maroko) at Harvard Medical School and Brigham and Women’s Hospital. He served as Assistant and then Associate Professor of Medicine at Harvard Medical School and as an attending cardiologist at Brigham and Women’s Hospital. There he received an Established Investigator Award of the American Heart Association (AHA). Dr. Kloner is a fellow of the American College of Cardiology, an Inaugural Fellow of the Council on Basic Cardiovascular Sciences of the AHA, and was elected to the American Society of Clinical Investigation. In 2015 he was elected a Fellow of the Cardiovascular Section of the American Physiology Society.
Hear Dr. Kloner on KFI-AM 640 talking about heart attacks and the Super Bowl on Thursday, February 2, 2017:
Dr. Kloner has made major contributions to the understanding of heart disease, including such concepts as no-reflow phenomenon, stunned myocardium, limitation of myocardial infarct size, remote ischemic conditioning (a phenomenon first described in his laboratory at the Heart Institute at Good Samaritan Hospital in Los Angeles, (Przyklenk et al 1993; Birnbaum et al 1997), post-reperfusion apoptosis, reperfusion phenomena and triggers of cardiovascular events. Other major research interests include cardiac cell transplantation, the effect of toxins on the heart, preventative cardiology, hypertension, PDE5 inhibition, and hemorrhagic shock. He has participated in studies funded by the National Institutes of Health on stunned myocardium, the healing phase of myocardial infarction, the effect of alcohol on the heart, cardiac cell transplantation, doxorubicin cardiomyopathy, functional analysis of cardiac grafts, and stem cells. He participated in studies funded by the American Heart Association on stunned myocardium and myocardial blood flow. He has participated in studies funded by the Environmental Protection Agency on pollution and the heart. He served on the NIH Cardiovascular Study Section A and participated in a number of NIH Workshops. He chaired an NIH workshop in September of 2010 on cardioprotection. He is currently working on a DOD funded project to assess new therapies for hemorrhagic shock.
A frequent contributor to the medical and scientific press, Dr. Kloner has authored or co-authored over 700 original papers in peer-reviewed journals, 218 chapters of monographs, and 506 abstracts (as of 2017). Dr. Kloner is the author and editor of 18 medical texts including: Cardiovascular Trials Reviews (10 editions), The Guide to Cardiology (3 editions), Stunned Myocardium, Ischemic Preconditioning, VIAGRA, and Heart Disease and Erectile Dysfunction, and three novels: The Beta Virus, Mind Cure, and The Deity Genes.
Among his editorial responsibilities, Dr. Kloner serves as editor-in-chief of the Journal of Cardiovascular Pharmacology and Therapeutics (since 2009). He has served as Guest Editor of Circulation. He is on the editorial boards of American Journal of Cardiology, Basic Research in Cardiology, International Journal of Impotence Research, Regenerative Medicine, Life Sciences and Journal of Men’s Health. Among his many career distinctions, Dr. Kloner has been listed in Who’s Who in America and The Best Doctors in America and in 2002 was identified by the Institute for Scientific Information as ISI Highly cited.com; one of the worlds’s most highly cited scientific authors. He has an H–index of 93 and is cited in the literature over 37,900 times as per the Web of Science. Dr. Kloner is a frequent lecturer at major scientific symposia including the Scientific Sessions of the American Heart Association, American College of Cardiology, and Transcatheter Cardiovascular Therapeutics Meetings, International Society of Heart Research, and he has lectured at most major academic medical centers in the United States. He has taught at both the Keck School of Medicine at USC and recently lectured at Caltech.